Figure 2From: Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survivalSurvivin gene levels measured in the peripheral blood of 70 patients with TNM stage I to IV gastric cancer. The trend test analysis shows a significant increase in Survivin transcriptional levels across patients with stage I to III gastric cancer (trend test P-value = 0.04). For each column is reported the mean ± SD.Back to article page